Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Effects of pharmacist-led interventions on asthma, CVD, and diabetes risk factors

From: The impact of clinical services provided by community pharmacies on the Australian healthcare system: a review of the literature

Determinant Effect Reference
Asthma control + 8% to + 12% [49]
Asthma severity score −0.3 (p < 0.002) [49]
Systolic blood pressure −6.32 mmHg (95% CI –8.8 to − 3.83; p < 0.001) [50]
Diastolic blood pressure −3.12 mmHg (95% CI –4.57 to − 1.67; p < 0.001) [50]
HbA1c level −0.75% (95% CI -1.41 to − 0.09; p = 0.03) [50]
Blood glucose level −7 to − 15 mg/dL [50]
Total cholesterol level −15 to − 37 mg/dL [50]
Triglyceride level −50.5 mg/dL [50]
  1. Abbreviations: CI confidence interval, HbA1c glycated haemoglobin
Back to article page